Deal targets link between quality and production data for life sciences manufacturers
Technology giant Honeywell has agreed to acquire Sparta Systems for $1.3 billion in an all-cash deal, which is expected to close by the end of Q1 2021. Sparta Systems is a provider of enterprise quality management software (QMS)—including its own software as a service (SaaS) platform—for the life sciences industry.
Honeywell plans to leverage the Sparta portfolio to introduce new, integrated products, such as QMS offerings, for life sciences and other segments, particularly through the company’s TrackWise Digital and QualityWise.ai software. In turn, executives say, this will increase access for Honeywell's pharma and biologics customers to higher-quality products in the form of new therapies, faster time to market, better business and patient outcomes, and regulatory compliance.
Honeywell says it will continue to develop TrackWise Digital QMS by implementing artificial intelligence and machine-learning features that augment human decision-making.
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
New UK Consortium Obtains $1.34M Grant to Launch Automated Cell Therapy Manufacturing Platform
July 15th 2025Cellular Origins, CGT Catapult, and Resolution Therapeutics partner up to design a fully automated, scalable CGT manufacturing solution, with the goal of accelerating patient access to cell therapies.